Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

CMXHF:US

72.4005 USD 0.1005 0.14%

As of 20:10:05 ET on 04/15/2015.

Snapshot for CSL Ltd (CMXHF)

Open: 72.4005 Day's Range: 72.4005 - 72.4005 Volume: 160
Previous Close: 72.3000 52wk Range: 60.6750 - 74.1536 1-Yr Rtn: -

Stock Chart for CMXHF

No chart data available.
  • CMXHF:US 72.4005
  • 1D
  • 1M
  • 1Y
72.3000
Interactive CMXHF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CMXHF

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) 24.3118
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (06/2015) 2.9780
Est. PEG Ratio 1.7328
Market Cap (M USD) 33,862.75
Shares Outstanding (M) 467.71
30 Day Average Volume 259
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.59%
Cash Dividend (AUD) 0.7439
Dividend Ex-Date 03/16/2015
5 Year Dividend Growth 12.04%
Next Earnings Announcement 08/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CMXHF

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CMXHF

CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection and pain medicine, skin disorder remedies, antivenoms, anticoagulants and immunoglobulins.

John ShineChairmanPaul PerreaultCEO/Managing Director
Gordon NaylorChief Financial OfficerMary SontropExec VP:Manufacturing
More Company Profile & Key Executives for CMXHF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil